{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T18:59:16Z","timestamp":1777316356218,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the 135 Project for Disciplines of Excellence, West China Hospital, Sichuan University","award":["No. ZYGD23031"],"award-info":[{"award-number":["No. ZYGD23031"]}]},{"name":"Sichuan Science and Technology Program","award":["No. 2023NSFSC1618"],"award-info":[{"award-number":["No. 2023NSFSC1618"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12072-025-10999-w","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T03:20:06Z","timestamp":1767496806000},"page":"342-352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genuine acute autoimmune hepatitis has better therapeutic response and prognosis"],"prefix":"10.1007","volume":"20","author":[{"given":"Yi","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoting","family":"Men","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoyao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3821-9342","authenticated-orcid":false,"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,4]]},"reference":[{"key":"10999_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.31065","volume":"72","author":"CL Mack","year":"2020","unstructured":"Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020;72:671\u2013722","journal-title":"Hepatology"},{"key":"10999_CR2","doi-asserted-by":"publisher","first-page":"14250","DOI":"10.1038\/s41598-020-71296-0","volume":"10","author":"A Takahashi","year":"2020","unstructured":"Takahashi A, Ohira H, Abe K, et al. Increasing incidence of acute autoimmune hepatitis: a nationwide survey in Japan. Sci Rep. 2020;10:14250","journal-title":"Sci Rep"},{"key":"10999_CR3","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s12072-024-10714-1","volume":"18","author":"A Tanaka","year":"2024","unstructured":"Tanaka A. Harada K Acute presentation of autoimmune hepatitis \u2013 from acute hepatitis to ALF and ACLF. Hepatol Int. 2024;18:1385\u20131395","journal-title":"Hepatol Int"},{"key":"10999_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/liv.15829","volume":"44","author":"M Ferronato","year":"2024","unstructured":"Ferronato M, Lalanne C, Quarneti C, et al. The evolving phenotype of autoimmune hepatitis across the millennium: the 40-year experience of a referral centre in Italy. Liver Int. 2024;44:791\u2013798","journal-title":"Liver Int"},{"key":"10999_CR5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/jclinpath-2016-204271","volume":"70","author":"H Nguyen Canh","year":"2017","unstructured":"Nguyen Canh H, Harada K, Ouchi H, et al. Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients. J Clin Pathol. 2017;70:961\u2013969","journal-title":"J Clin Pathol"},{"key":"10999_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12072-018-9848-z","volume":"12","author":"K Fujiwara","year":"2018","unstructured":"Fujiwara K, Fukuda Y, Seza K, et al. Long-term observation of acute-onset autoimmune hepatitis presenting clinically and radiologically as acute hepatitis. Hepatol Int. 2018;12:191\u2013199","journal-title":"Hepatol Int"},{"key":"10999_CR7","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.dld.2018.02.015","volume":"50","author":"P Muratori","year":"2018","unstructured":"Muratori P, Carbone M, Stangos G, et al. Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: an Italian multicentre study. Dig Liver Dis. 2018;50:698\u2013702","journal-title":"Dig Liver Dis"},{"key":"10999_CR8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1872-034X.2008.00347.x","volume":"38","author":"M Iwai","year":"2008","unstructured":"Iwai M, Jo M, Ishii M, et al. Comparison of clinical features and liver histology in acute and chronic autoimmune hepatitis. Hepatol Res. 2008;38:784\u2013789","journal-title":"Hepatol Res"},{"key":"10999_CR9","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1111\/liv.14946","volume":"41","author":"Y Shen","year":"2021","unstructured":"Shen Y, Xue M, Yang L. Letter to the editor: both simplified and revised IAIHG scores should be considered in diagnosing acute autoimmune hepatitis. Liver Int. 2021;41:1973\u20131975","journal-title":"Liver Int"},{"key":"10999_CR10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929\u2013938","journal-title":"J Hepatol"},{"key":"10999_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169\u2013176","journal-title":"Hepatology"},{"key":"10999_CR12","doi-asserted-by":"crossref","unstructured":"Scheuer PJ, Standish RA, Dhillon AP. Scoring of chronic hepatitis. Clin Liver Dis 2002;6:335\u2013347, v\u2013vi","DOI":"10.1016\/S1089-3261(02)00009-0"},{"key":"10999_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","volume":"76","author":"S Pape","year":"2022","unstructured":"Pape S, Snijders R, Gevers TJG, et al. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group. J Hepatol. 2022;76:841\u2013849","journal-title":"J Hepatol"},{"key":"10999_CR14","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/apt.12701","volume":"39","author":"AJ Czaja","year":"2014","unstructured":"Czaja AJ. Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis. Aliment Pharmacol Ther. 2014;39:1043\u20131058","journal-title":"Aliment Pharmacol Ther"},{"key":"10999_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2024.101497","volume":"29","author":"LR Guedes","year":"2024","unstructured":"Guedes LR, Can\u00e7ado GGL, Santos BC, et al. Clinical, biochemical and histological features related to treatment response and prognosis in autoimmune hepatitis. Ann Hepatol. 2024;29: 101497","journal-title":"Ann Hepatol"},{"key":"10999_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3513206","volume":"2018","author":"Y Shen","year":"2018","unstructured":"Shen Y, Lu C, Men R, et al. Clinical and pathological characteristics of autoimmune hepatitis with acute presentation. Can J Gastroenterol Hepatol. 2018;2018: 3513206","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10999_CR17","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/ueg2.12582","volume":"12","author":"A Eshraghian","year":"2024","unstructured":"Eshraghian A, Taghavi A, Nikeghbalian S. Outcomes of patients with acute severe autoimmune hepatitis: predictors of non-response to corticosteroids and need for liver transplantation. United Eur Gastroenterol J. 2024;12:911\u2013918","journal-title":"United Eur Gastroenterol J"},{"key":"10999_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jhep.2009.02.026","volume":"51","author":"AJ Czaja","year":"2009","unstructured":"Czaja AJ. Rapidity of treatment response and outcome in type 1 autoimmune hepatitis. J Hepatol. 2009;51:161\u2013167","journal-title":"J Hepatol"},{"key":"10999_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","volume":"83","author":"European Association for the Study of the Liver","year":"2025","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of autoimmune hepatitis. J Hepatol. 2025;83:453\u2013501","journal-title":"J Hepatol"},{"key":"10999_CR20","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1111\/jgh.16657","volume":"39","author":"K Fujiwara","year":"2024","unstructured":"Fujiwara K, Fukuda Y, Sanada M, et al. Analysis of autoimmune hepatitis with acute presentation in the early stage of illness. J Gastroenterol Hepatol. 2024;39:2120\u20132128","journal-title":"J Gastroenterol Hepatol"},{"key":"10999_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","volume":"20","author":"Y Sumida","year":"2014","unstructured":"Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J Gastroenterol. 2014;20:475\u2013485","journal-title":"World J Gastroenterol"},{"key":"10999_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4254\/wjh.v4.i9.262","volume":"4","author":"K Abe","year":"2012","unstructured":"Abe K, Kanno Y, Okai K, et al. Centrilobular necrosis in acute presentation of Japanese patients with type 1 autoimmune hepatitis. World J Hepatol. 2012;4:262\u2013267","journal-title":"World J Hepatol"},{"key":"10999_CR23","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.jhep.2020.07.023","volume":"73","author":"AW Lohse","year":"2020","unstructured":"Lohse AW, Sebode M, J\u00f8rgensen MH, et al. Second-line and third-line therapy for autoimmune hepatitis: a position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group. J Hepatol. 2020;73:1496\u20131506","journal-title":"J Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10999-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-025-10999-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10999-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T18:29:41Z","timestamp":1777314581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-025-10999-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10999"],"URL":"https:\/\/doi.org\/10.1007\/s12072-025-10999-w","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,4]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yi Shen, Dan Zhou, Jie Sun, Xiaoze Wang, Ruoting Men, Maoyao Wen, Xiaoli Fan, Xianglin Wang, Fan Yang, and Li Yang declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008, and an exemption from obtaining informed consent was granted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent in studies with human subjects"}},{"value":"This article does not contain any studies with animal subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}}]}}